Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Awada H, Abdelmalek M, Cronin T, Baron J, Kashour Z, Azad F, Faisal MS, Faber M, Gravina M, Sung PJ, Green SD, Przespolewski A, Thompson JE, Griffiths EA, Wang ES. Awada H, et al. Among authors: przespolewski a. Blood Cancer J. 2023 Sep 4;13(1):131. doi: 10.1038/s41408-023-00910-x. Blood Cancer J. 2023. PMID: 37666807 Free PMC article. No abstract available.
Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone.
Singh A, Thota S, Bradley T, Griffiths EA, Faber MG, Sadek S, Przespolewski A, Thompson JE, Baron J, Cronin T, Attwood K, Madarang EC, Watts J, Wang ES. Singh A, et al. Among authors: przespolewski a. Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):613-620. doi: 10.1016/j.clml.2021.04.007. Epub 2021 Apr 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34031004 Free PMC article.
FLT3-mutated acute myeloid leukaemia: a new opportunity.
Przespolewski AC, Griffiths EA. Przespolewski AC, et al. Lancet. 2023 May 13;401(10388):1546-1548. doi: 10.1016/S0140-6736(23)00617-7. Epub 2023 Apr 25. Lancet. 2023. PMID: 37116522 No abstract available.
Advances in immunotherapy for acute myeloid leukemia.
Przespolewski A, Szeles A, Wang ES. Przespolewski A, et al. Future Oncol. 2018 Apr;14(10):963-978. doi: 10.2217/fon-2017-0459. Epub 2018 Mar 15. Future Oncol. 2018. PMID: 29542352 Free article. Review.
Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy.
Przespolewski A, Muppidi MR, Freyer CW, Ji W, Cronin TL, Thota S, Griffiths EA, Thompson JE, Ontiveros EP, Baron J, Elshoury A, Wang ES. Przespolewski A, et al. Leuk Lymphoma. 2021 Jul;62(7):1778-1781. doi: 10.1080/10428194.2021.1885654. Epub 2021 Feb 16. Leuk Lymphoma. 2021. PMID: 33593230 No abstract available.
20 results